Formulation and Evaluation of Bilayer Tablets of Granisetron HCl and Ibuprofen for the Treatment of Migraine

Background of the Topic: The major purpose of this study was to produce a bilayer pill that contained Granisetron HCl (GSH) and ibuprofen (IBF) in distinct layers to minimize the possibility of adverse drug interactions and maximize the efficacy of both medications when they were combined to treat the symptoms of migraines. In contrast to the IBF layer, the GSH layer was intended to have a more gradual release of its contents. Methods: Microcrystalline cellulose, sodium starch glycolate, and croscarmellose sodium were the chemicals used to create the rapid-release layer. Isopropyl alcohol, magnesium stearate, and HPMC K 4M were among the polymers and gums that were used in the process of producing the continuous release layer. First, the fine-tuning process was performed on the tablet's two layers. After that, the layers necessary for quick as well as extended-release were put together. There were no adverse reactions caused by the active components interacting with the excipients. The rate at which a medicine is absorbed into the body may be sped up by using Croscarmellose sodium in a formulation. Results: A combination is given a delayed release influence by the addition of HPMC K 4M. The bilayer tablet forms from the improved (IR-4) batch were found to have strong linearity as shown by the regression coefficient of 0.9773, which is a first-order equation. According to the results, a bilayer pill that has both an increased IR-4 GSH immediate release layer and an SR-5 IBF sustained release layer would be an effective way to treat migraines. Conclusion: Bilayer tablets with releasing qualities provide a wide variety of benefits, some of which include the ability to localize medication administration, enhanced absorption, and improved effectiveness.